The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters

American Journal of Surgical Pathology

Volumn 37, Issue 10, 2013, Pages 1490-1504

  Delahunt, Brett ^a   Cheville, John C ^b   Martignoni, Guido ^f   Humphrey, Peter A ^c   Magi Galluzzi, Cristina ^d   McKenney, Jesse ^d   Egevad, Lars ^h   Algaba, Ferran ⁱ   Moch, Holger ^j   Grignon, David J ^e   Montironi, Rodolfo ^g   Srigley, John R ^k,l   Abraham, Anila ^m   Adeniran, Adebowale ^m   Ahmed, Khalid ^m   Al Ahmadie, Hikmat ^m   Allan, Robert ^m   Amin, Mahul ^m   Argani, Pedram ^m   Axcrona, Ulrika ^m   Barry, Marc ^m   Baydar, Dilek ^m   Bégin, Louis ^m   Berney, Dan ^m   Bethwaite, Peter ^m   Billis, Athanase ^m   Birbe, Ruth ^m   Bonsib, Stephen ^m   Bostwick, David ^m   Brimo, Fadi ^m   Cathro, Helen ^m   Chen, Ying Bei ^m   Cheng, Liang ^m   Cho, Yong Mee ^m   Chuang, Ai Ying ^m   Cohen, Cynthia ^m   Crist, Henry ^m   Delprado, Warick ^m   Deng, Fang Ming ^m   Epstein, Jonathan ^m   Evans, Andrew ^m   Fadare, Oluwole ^m   Fajardo, Daniel ^m   Falzarano, Sara ^m   Fine, Samson ^m   Fleming, Stewart ^m   Fridman, Eddie ^m   Furusato, Bungo ^m   Ganji, Masoud ^m   Ghayouri, Masoumeh ^m   Giannico, Giovanna ^m   Gokden, Neriman ^m   Griffiths, David ^m   Gupta, Nilesh ^m   Hameed, Omar ^m   Hes, Ondrej ^m   Hirsch, Michelle ^m   Huang, Jiaoti ^m   Huang, Wei ^m   Van De Kaa, Christina Hulsbergen ^m   Hussein, Sundus ^m   Iczkowski, Kenneth ^m   Jimenez, Rafael ^m   Jones, Edward ^m   Jufe, Laura Irene ^m   Kench, James ^m   Kida, Masatoshi ^m   Kristiansen, Glen ^m   Kunju, Lakshmi Priya ^m   Lane, Zhaoli ^m   Latour, Mathieu ^m   Lewin, Claudio ^m   Lie, Kathrine ^m   Lloreta, Josep ^m   Loftus, Barbara ^m   Lopez Beltran, Antonio ^m   Maclean, Fiona ^m   McHale, Teresa ^m   Merino, Maria ^m   Miller, Rose ^m   Miyamoto, Hiroshi ^m   Murphy, Hedwig ^m   Nacey, John ^m   Nazeer, Tipu ^m   Nesi, Gabriella ^m   Netto, George ^m   Nichols, Peter ^m   O'Donnell, Marie ^m   Olgac, Semra ^m   Orozco, Roberto ^m   Osunkoya, Adeboye ^m   Ozagari, Aysim ^m   Pan, Chin Chen ^m   Parwani, Anil ^m   Perry Keene, Joanna ^m   Petraki, Constantina ^m   Picken, Maria ^m   Pyda Karwicka, Maria ^m   Reuter, Victor ^m   Rezaei, Katayoon ^m   Rioux Leclercq, Nathalie ^m   Robinson, Brian ^m   Rohan, Stephen ^m   Ronchetti, Ruben ^m   Russell, Laurie ^m   Scarpelli, Marina ^m   Shabaik, Ahmed ^m   Shah, Rajal ^m   Shanks, Jonathan ^m   Shen, Steven ^m   Shevchuk, Maria ^m   Sibony, Mathilde ^m   Srinivasan, Bhuvana ^m   Susani, Martin ^m   Suzigan, Sueli ^m   Sweet, Joan ^m   Takahashi, Hiroyuki ^m   Tan, Puay Hoon ^m   Tickoo, Satish ^m   Trias, Isabel ^m   True, Larry ^m   Tsuzuki, Toyonori ^m   Vakar Lopez, Funda ^m   Van Der Kwast, Theo ^m   Wang, Cheng ^m   Warren, Anne ^m   Yao, Jorge ^m   Yilmaz, Asli ^m   Zhao, Jin ^m   Zhou, Ming ^m   Zynger, Debra ^m   more..

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MAYO CLINIC   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF VERONA   (Italy)

^g UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ FUNDACIÓ PUIGVERT   (Spain)

^j UNIVERSITY OF ZURICH   (Switzerland)

^k CREDIT VALLEY HOSPITAL   (Canada)

^l MCMASTER UNIVERSITY   (Canada)

^m NONE

more..

Author keywords

Grade; International Society of Urological Pathology; Kidney; Microvascular invasion; Necrosis; Pathology; Renal cell carcinoma; Rhabdoid differentiation; Sarcomatoid differentiation; Tumor morphotype

Indexed keywords

EID: 84902548073     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318299f0fb     Document Type: Article

References (125)

1. Srigley JR, Hutter RVP, Gelb AB, et al. Current prognostic factors-renal cell carcinoma. Cancer. 1997;80:993-996.
2. Gudbjartsson T, Hardarson S, Petursdottir V, et al. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol. 2005;48:593-600.
3. Delahunt B. Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol. 2009;22:S24-S36.
4. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcomes and prognostic feature among histological subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612-624.
5. Delahunt B, Bethwaite PB, Nacey JN. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology. 2007;39:459-465.
6. Ficarra V, Martignoni G, Maffei N, et al. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer. 2005;103:68-75.
7. Delahunt B, Egevad L, Montironi R, et al. International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. Am J Surg Pathol. 2013;37:1463-1468.
8. Egevad L, Srigley JR, Delahunt B. International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens: rationale and organization. Mod Pathol. 2011;24:1-5.
9. Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol. 2013;37:e12-e32.
10. Trpkov K, Grignon DJ, Bonsib SM, et al. Handling and staging of renal cell carcinoma: the International Society of Urological Pathology (ISUP) recommendations. Am J Surg Pathol. 2013;37:e48-e60.
11. Tan PH, Cheng L, Rioux-Leclercq N, et al. Renal tumors: diagnostic and prognostic markers. Am J Surg Pathol. 2013; 37:e61-e74.
12. Mostofi FK. Histological Typing of Kidney Tumours. World Health Organization. Geneva: International Histological Classification of Tumours No. 25; 1981.
13. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004.
14. Moch H, Gasser T, Amin MB, et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000;89:604-614.
15. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms. Am J Surg Pathol. 2002;26:281-291.
16. Beck SD, Patel MI, Snyder ME, et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol. 2004;11:71-77.
17. Ficarra V, Martignoni G, Alfano G, et al. Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision. Eur Urol. 2006;50:786-794.
18. Patard JJ, Leray E, Rioux-Leclerq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23:2763-2767.
19. Capitanio U, Cloutier V, Zini L, et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a populationbased study. BJU Int. 2009;103:1496-1500.
20. Novara G, Ficarra V, Antonelli A, et al. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol. 2010;58:588-595.
21. Kovacs G, Akhtar M, Beckwith JB, et al. The Heidelberg classification of renal cell tumours. J Pathol. 1997;183:131-133.
22. Sto rkel S, Eble JN, Adlakha K, et al. Classification of renal carcinoma. Cancer. 1997;80:987-989.
23. Leibovich BC, Lohse CM, Crispen PL, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010;183:1309-1316.
24. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537-544.
25. Gunawan B, von HA, Fritsch T, et al. Cytogenetic and morphologic typing of papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors. Cancer Res. 2003;63:6200-6205.
26. Pignot G, Elie C, Conquy S, et al. Survival analysis of 130 patients with papillary renal cell carcinomas: prognostic utility of type 1 and type 2 subclassification. Urology. 2007;69:230-235.
27. Delahunt B, Eble JN, McCredie MRE, et al. Morphological typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32: 590-595.
28. Mejean A, Hopirtean V, Bazin JP, et al. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol. 2003;170:764-767.
29. Waldert M, Haitel A, Marberger M, et al. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC. BJU Int. 2008;102:1381-1384.
30. Sukov WR, Lohse CM, Leibovich BC, et al. Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma. J Urol. 2012;187:54-59.
31. Tickoo SK, Reuter VE. Differential diagnosis of renal tumors with papillary architecture. Adv Anat Pathol. 2011;18:120-132.
32. Tokuda N, Naito S, Matsuzaki O, et al. Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol. 2006;176:40-43.
33. Wright JL, Risk MC, Hotaling J, et al. Effect of collecting duct histology on renal cell cancer outcome. J Urol. 2009;182:2595-2599.
34. Srigley JR, Delahunt B. Uncommon and recently described renal carcinomas. Mod Pathol. 2009;22:S2-S23.
35. Aydin H, Chen L, Cheng L, et al. Clear cell tubulopapillary renal cell carcinoma: A study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol. 2010;34:1608-1621.
36. Abel EJ, Carrasco A, Culp SH, et al. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases. BJU Int. 2012;110:1742-1746.
37. Baer SC, RO JY, Ordonez NG, et al. Sarcomatoid collecting duct carcinoma: a clinicopathologic and immunohistochemical study of five cases. Hum Pathol. 1993;24:1017-1022.
38. Bostrom AK, Moller C, Nilsson E, et al. Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-tomesenchymal transition. Hum Pathol. 2012;43:708-719.
39. Brunelli M, Gobbo S, Cossu-Rocca P, et al. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol. 2007;20:303-309.
40. Cangiano T, Liao J, Naitoh J, et al. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy. J Clin Oncol. 1999;17:523-528.
41. Cheville JC, Lohse CM, Zincke H, et al. Sarcomatoid renal cell carcinoma. An examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol. 2004;28:435-441.
42. Cheville JC, Lohse CM, Sukov WR, et al. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome. Am J Surg Pathol. 2012;36:851-856.
43. Delahunt B. Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology. 1993;31:185-190.
44. Delahunt B, Bethwaite PB, McCredie MR, et al. The evolution of collagen expression in sarcomatoid renal cell carcinoma. Hum Pathol. 2007;38:1372-1377.
45. de Peralta-Venturina M, Moch H, Amin M, et al. Sarcomatoid differentiation in renal cell carcinoma. A study of 101 cases. Am J Surg Pathol. 2001;25:275-284.
46. Dhillon J, Amin MB, Selbs E, et al. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Am J Surg Pathol. 2009;33:44-49.
47. Farrow GM, Harrison EG, Utz DC. Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. Part III. Cancer. 1968;22:556-563.
48. Jiang F,Moch H, Richter J, et al. Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation. J Pathol. 1998;185:382-388.
49. Jones TD, Eble JN, Wang M, et al. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation. Cancer. 2005;104:1195-1203.
50. Kuroda N, Tamura M, Hamaguschi N, et al. Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features. Ann Diagn Pathol. 2011;15:462-466.
51. Li YF, Cha TL, Jin JS, et al. Chromophobe renal cell carcinoma with osteosarcoma differentiation: case report and literature review. Urol Int. 2010;85:470-474.
52. Mian BM, Bhadkamkar N, Slaton JW, et al. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol. 2002;167:65-70.
53. Molina AM, Tickoo SK, Ishill N, et al. Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease. Am J Clin Oncol. 2011;34:454-459.
54. Murphy WM, Grignon DJ, Perlman EJ. Kidney tumors in adults, Chapter
55. Tumors of the Kidney, Bladder and Related Urinary Structures. AFIP Atlas of Tumor Pathology, Series
56. Washington, DC: American Registry of Pathology; 2004:145-148.
57. Pagliaro LC, Tannir N, Sicar K, et al. Systemic therapy for sarcomatoid renal cell carcinoma. Expert Rev Anticancer Ther. 2011;11:913-920.
58. Przybycin CG, Cronin AM, Darvishian F, et al. Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution. Am J Surg Pathol. 2011;35:963-970.
59. Quiroga-Garza G, Khurana H, Shen S, et al. Sarcomatoid chromophobe renal cell carcinoma with heterologous sarcomatoid elements. A case report and review of the literature. Arch Pathol Lab Med. 2009;133:1857-1860.
60. Ro JY, Ayala AG, Sella A, et al. Sarcomatoid renal cell carcinoma: clinicopathologic: a study of 42 cases. Cancer. 1987;59:516-526.
61. Shuch B, Bratslavsky G, Linehan WM, et al. Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist. 2012;17:46-54.
62. Shuch B, Bratslavsky G, Shih J, et al. Impact of pathological tumor characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int. 2012;109:1600-1606.
63. Srigley JR, Amin MB, Delahunt B, et al. Protocol for examination of specimens from patients with invasive carcinoma of renal tubular origin. Arch Pathol Lab Med. 2010;134:e25-e30.
64. Tomera KM, Farrow GM, Lieber MM. Sarcomatoid renal carcinoma. J Urol. 1983;130:657-659.
65. Gokden N, Nappi O, Swanson PE, et al. Renal cell carcinoma with rhabdoid features. Am J Surg Pathol. 2000;24:1329-1338.
66. Perez-Montiel MD, Frankel WL, Suster P, et al. Neuroendocrine carcinomas of the pancreas with 'Rhabdoid' features. Am J Surg Pathol. 2003;27:642-649.
67. Cheng JX, Tretiakova M, Gong C, et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008;21:647-652.
68. Kuroiwa K, Kinoshita Y, Shiratsuchi H, et al. Renal cell carcinoma with rhabdoid features: an aggressive neoplasm. Histopathology. 2002;41:538-548.
69. Shannon B, Wisniewski ZS, Bentel J, et al. Adult rhabdoid renal cell carcinoma. Arch Pathol Lab Med. 2002;126:1506-1510.
70. Leroy X, Zini L, Buob L, et al. Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53. Arch Pathol Lab Med. 2007;31:102-106.
71. Weeks DA, Beckwith JB, Mierau GW, et al. Renal neoplasms mimicking rhabdoid tumor of kidney. A report from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol. 1991;15:1042-1054.
72. Shannon BA, Cohen RJ. Rhabdoid differentiation of chromophobe renal cell carcinoma. Pathology. 2003;35:228-230.
73. Sukov WR, Cheville JC, Lager DJ, et al. Malignant mixed epithelial and stromal tumor of the kidney with rhabdoid features: report of a case including immunohistochemical, molecular genetic studies and comparison to morphologically similar renal tumors. Hum Pathol. 2007;38:1432-1437.
74. Humphrey PA. Renal cell carcinoma with rhabdoid features. J Urol. 2011;186:675-676.
75. Ma J, Zhou XJ, Huang WB, et al. Clinicopathologic study of renal cell carcinoma with rhabdoid features. Zhonghua Bing Li Xue Za Zhi. 2007;36:166-170.
76. Chapman-Fredricks JR, Herrera L, Brancho J, et al. Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma. Ann Diagn Pathol. 2011;15:333-337.
77. Klimis T, Karvounis H. Renal cell carcinoma with rhabdoid features. divergent differentiation of conventional (clear cell) carcinoma. J BUON. 2008;13:433-436.
78. Kapoor A, Tutino R, Kanaroglou A, et al. Treatment of adult rhabdoid renal cell carcinoma with sorafenib. Can Urol Assoc J. 2008;2:631-634.
79. Shen R, Wen P. Clear cell renal cell carcinoma with syncytial giant cells: a case report and review of the literature. Arch Pathol Lab Med. 2004;128:1435-1438.
80. De Vincenzo F, Zucali PA, Corenzi E, et al. Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma. J Clin Oncol. 2011;29:e529-e531.
81. Lee SE, Byun SS, Oh JK, et al. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. J Urol. 2006;176:1332-1338.
82. Katz MD, Serrano MF, Grubb RL III, et al. Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 2010;183:909-914.
83. Isbarn H, Patard JJ, Lughezzani G, et al. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma. Urology. 2010;75:1378-1384.
84. Pichler M, Hutterer GC, Chromecki TF, et al. Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol. 2012;137: 283-289.
85. Brinker DA, Amin MB, de Peralta-Venturina M, et al. Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers. Am J Surg Pathol. 2000;24:988-995.
86. Faria V, Surendra T, Poller DN. Prognostic relevance of extensive necrosis in renal cell carcinoma. J Clin Pathol. 2005;58:39-43.
87. Hemmerlein B, Kugler A, Ozisik R, et al. Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas. Virchows Arch. 2001;439:645-652.
88. Delahunt B, Bethwaite PB, Thornton A. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br J Urol. 1997;80:401-404.
89. Delahunt B, McKenney JK, Lohse CM, et al. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. Am J Surg Pathol. 2013;37:311-322.
90. Amtrup F, Hansen JB, Thybo E. Prognosis in renal carcinoma evaluated from histological criteria. Scand J Urol Nephrol. 1974;8:198-202.
91. Delahunt B, Nacey JN. Renal cell carcinoma: histological indicators of prognosis. Pathology. 1987;19:258-263.
92. Lam JS, Shvarts O, Said JW, et al. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer. 2005;103:2517-2525.
93. Cheville JC, Blute ML, Zincke H, et al. Stage pT1 conventional (clear cell) renal cell carcinoma: pathological features associated with cancer specific survival. J Urol. 2001;166:453-456.
94. Frank I, Blute ML, Cheville JC, et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002;168:2395-2400.
95. Leibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97:1663-1671.
96. Sengupta S, Lohse CM, Leibovich BC, et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer. 2005;104:511-520.
97. Ficarra V, Martignoni G, Lohse C, et al. External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol. 2006;175:1235-1239.
98. Thompson RH, Leibovich BC, Lohse CM, et al. Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. J Urol. 2007;177:477-480.
99. Tollefson MK, Thompson RH, Sheinin Y, et al. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Cancer. 2007;110:783-790.
100. Zubac DP, Bostad L, Gestblom C, et al. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy. Scand J Urol Nephrol. 2007;41:191-197.
101. Sorbellini M, Kattan MW, Snyder ME, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol. 2005;173: 48-51.
102. Klatte T, Remzi M, Zigeuner RE, et al. Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma. J Urol. 2010; 184:53-58.
103. Minervini A, Di Cristofano C, Gacci M, et al. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. J Urol. 2008;180:1284-1289.
104. Kim H, Cho NH, Kim DS, et al. Renal cell carcinoma in South Korea: a multicenter study. Hum Pathol. 2004;35:1556-1563.
105. Hand JR, Broders AC. Carcinoma of the kidney: the degree of malignancy in relation to factors bearing on prognosis. J Urol. 1932;28:199-216.
106. Griffiths IH, Thackray AC. Parenchymal carcinoma of the kidney. Br J Urol. 1949;21:128-151.
107. Skinner DG, Colvin RB, Vermillion CD, et al. Diagnosis and management of renal cell carcinoma: a clinical and pathologic study of 309 cases. Cancer. 1971;28:1165-1177.
108. Fuhrman SA, Lasky LC, Limas C. Prognostic significance in morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:656-663.
109. Goldstein N. Grading of renal cell carcinoma. Urol Clin North Am. 1999;26:637-642.
110. Sika-Paotonu D, Bethwaite PB, McCredie MRE, et al. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol. 2006;30:1091-1096.
111. Delahunt B, Sika-Paotonu D, Bethwaite PB, et al. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Am J Surg Pathol. 2011;135:1134-1139.
112. Delahunt B, Sika-Paotonu D, Bethwaite PB, et al. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol. 2007;31:957-960.
113. Paner GP, Amin MB, Alvarado-Cabrero I, et al. A novel tumor grading scheme for chromophobe renal cell carcinoma. prognostic utility and comparison with Fuhrman nuclear grade. Am J Surg Pathol. 2010;34:1233-1240.
114. Cho HJ, Kim SJ, Ha US, et al. Prognostic value of capsular invasion for localized clear-cell renal cell carcinoma. Eur Urol. 2009;56:1006-1012.
115. Griffiths DF, Verghese A, Golash A, et al. Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma. BJU Int. 2002;90:26-31.
116. Ishimura T, Sakai I, Hara I, et al. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery. Int J Urol. 2004;11:264-268.
117. Lang H, Lindner V, Letourneux H, et al. Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up. Eur Urol. 2004;46:331-335.
118. Madbouly K, Al-Qahtani SM, Ghazwani Y, et al. Microvascular tumor invasion: prognostic significance in low-stage renal cell carcinoma. Urology. 2007;69:670-674.
119. Miyagawa T, Shimazui T, Hinotsu S, et al. Does tumor size or microvascular invasion affect prognosis in patients with renal cell carcinoma? Jpn J Clin Oncol. 2007;37:197-200.
120. Roos FC, Weirich J, Victor A, et al. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma. BJU Int. 2009;104:461-469.
121. Van Poppel H, Vandendriessche H, Boel K, et al. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. J Urol. 1997;158:45-49.
122. Pichler M, Hutterer GC, Chromecki TF, et al. External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology. J Urol. 2011;186:1773-1777.
123. Sevinc M, Kirkali Z, Yorukoglu K, et al. Prognostic significance of microvascular invasion in localized renal cell carcinoma. Eur Urol. 2000;38:728-733.
124. Kroeger N, Rampersand EN, Patard JJ, et al. Prognostic value of microvascular invasion in predicting cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol. 2012;187:418-423.
125. Pichler M, Hutterer GC, Chromecki TF, et al. Prognostic value of the Leibovich prognosis score supplemented by vascular invasion for clear cell renal cell carcinoma. J Urol. 2012;187:834-839.